Abstract:Abstract Introduction Hematopoietic stem cells (HSCs) sustain lifelong blood production and can be used in allogenic stem cell transplantation for treatment of hematological malignancies, yet the mechanisms of their DNA damage response (DDR) remain largely unexplored. Genotoxic damage can be induced by chemotherapeutical agents (eg, etoposide, a topoisomerase II inhibitor) or by methylating agents (eg, nitrosamines). Related double strand breaks (DSBs) at the level of immature cells are thus presumed to trigger leukemia. Objective Human quiescent and cycling HSCs were reported to exhibit distinct responses to genotoxic stress upon in vitro exposure to sublethal doses of etoposide or N-nitroso-N-methylurea (MNU). In this context, we aim to identify and compare the mechanisms involved in the determination of HSC stem and progenitor cell fate upon DNA damage to gain more insights into cytotoxic anticancer drug- and contaminant-related hematological toxicity. Methods Quiescent human HSCs (CD34+) were isolated from umbilical cord blood, sorted and directly exposed to etoposide or MNU. Besides, CD34+ were expanded in-vitro in medium containing broad acting cytokines for 5 days prior genotoxic exposure. Sublethal doses were assessed by Alamar Blue assay. Propidium iodide staining and colony-forming unit assay (CFU) were used for cell cycle analysis and tracking of cell functionality. Results In vitro inhibitory concentrations were identified for human HSCs treated with etoposide (IC50 = 5 μM) and MNU (IC50 = 1 mM). Treatment of quiescent HSCs with lower genotoxin concentrations induces a cell cycle arrest in the G0/G1-phase, whereas higher concentrations activate apoptosis-related genes and completely abrogate further differentiation into colony-forming progenitors. In contrast, cycling HSCs exhibit an impaired proliferation, upregulation of autophagy-related genes, reduced proportions of viable CD34+ cells, and similar effects regarding differentiation capacity into colony-forming progenitors. However, cells exposed to lower genotoxin doses exhibit a higher regeneration capacity 3 days upon treatment. Discussion These results confirm that the DDR following DSB-induction differs between quiescent and cycling HSCs. Quiescent HSCs exhibit a stronger DDR, probably related to their longer lifespan. To avoid malignant transformation, it is necessary to preclude damage accumulation through cell cycle withdrawal and apoptosis. In contrast, more committed cells rather inline toward damage repair and restoration through activation of, for example, non-homologous end joining or mismatch repair genes.

Abstract 1 Distinctive and Differentiation-State Dependent DNA Damage Response of Hematopoietic Stem Cells to Genotoxic Noxae

Evaluation of human embryonic stem cells and their differentiated fibroblastic progenies as cellular models for in vitro genotoxicity screening.

DNA damage response after treatment of cycling and quiescent cord blood hematopoietic stem cells with distinct genotoxic noxae

Human Embryonic Stem Cells May Display Higher Resistance to Genotoxic Stress As Compared to Primary Explanted Somatic Cells.

Differential Resistance of Human Embryonic Stem Cells and Somatic Cell Types to Hydrogen Peroxide-Induced Genotoxicity May Be Dependent on Innate Basal Intracellular ROS Levels.

DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.

DNA Damage and Repair in the Hematopoietic System

Crosstalk between DNA Damage Repair and Metabolic Regulation in Hematopoietic Stem Cells

Mitochondrial Dysfunction and Oxidative Stress in Bone Marrow Stromal Cells Induced by Daunorubicin Leads to DNA Damage in Hematopoietic Cells.

Heterogeneous Formation of DNA Double-Strand Breaks and Cell-Free DNA in Leukemia T-Cell Line and Human Peripheral Blood Mononuclear Cells in Response to Topoisomerase II Inhibitors

The DNA damage and regulatory strategy in hematopoietic stem cells after irradiation exposure: Progress and challenges

DNA Damage Response in Hematopoietic Stem Cell Ageing

The role of DNA repair in the pluripotency and differentiation of human stem cells

Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response

Compromised Hematopoiesis and Increased DNA Damage Following Non-Lethal Ionizing Radiation of a Human Hematopoietic System Reconstituted in Immunodeficient Mice

HMCES Safeguards Genome Integrity and Long-Term Self-Renewal of Hematopoietic Stem Cells During Stress Responses.

The regulation of hematopoietic stem cell fate in the context of radiation

Apoptosis and Senescence – Main Mechanisms of Accelerated Aging of Haematopoietic Cells after Irradiation

Sensitivity and dose dependency of radiation-induced injury in hematopoietic stem/progenitor cells in mice

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies

Lethal and sublethal effects of programmed cell death pathways on hematopoietic stem cells